| Literature DB >> 22844457 |
Igor Mokrousov1, Anna Vyazovaya, Tatiana Otten, Viacheslav Zhuravlev, Elena Pavlova, Larisa Tarashkevich, Valery Krishevich, Boris Vishnevsky, Olga Narvskaya.
Abstract
This study aimed to characterize the population structure of Mycobacterium tuberculosis in Pskov oblast in northwestern Russia, to view it in the geographical context, to compare drug resistance properties across major genetic families. Ninety M. tuberculosis strains from tuberculosis (TB) patients, permanent residents in Pskov oblast were subjected to LAM-specific IS6110-PCR and spoligotyping, followed by comparison with SITVITWEB and MIRU-VNTRplus databases. The Beijing genotype (n = 40) was found the most prevalent followed by LAM (n = 18), T (n = 13), Haarlem (n = 10), Ural (n = 5), and Manu2 (n = 1); the family status remained unknown for 3 isolates. The high rate of Beijing genotype and prevalence of LAM family are similar to those in the other Russian settings. A feature specific for M. tuberculosis population in Pskov is a relatively higher rate of Haarlem and T types. Beijing strains were further typed with 12-MIRU (followed by comparison with proprietary global database) and 3 hypervariable loci QUB-3232, VNTR-3820, VNTR-4120. The 12-MIRU typing differentiated 40 Beijing strains into 14 types (HGI = 0.82) while two largest types were M2 (223325153533) prevalent throughout former USSR and M11 (223325173533) prevalent in Russia and East Asia. The use of 3 hypervariable loci increased a discrimination of the Beijing strains (18 profiles, HGI = 0.89). Both major families Beijing and LAM had similar rate of MDR strains (62.5 and 55.6%, respectively) that was significantly higher than in other strains (21.9%; P = 0.001 and 0.03, respectively). The rpoB531 mutations were more frequently found in Beijing strains while LAM drug resistant strains mainly harbored rpoB516 and inhA -15 mutations. Taken together with a high rate of multidrug resistance among Beijing strains from new TB cases (79.3% versus 44.4% in LAM), these findings suggest the critical impact of the Beijing genotype on the current situation with MDR-TB in the Pskov region in northwestern Russia.Entities:
Mesh:
Year: 2012 PMID: 22844457 PMCID: PMC3402494 DOI: 10.1371/journal.pone.0041318
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Spoligotypes of M. tuberculosis strains from Pskov area in Russia.
| SIT | Family | Number of strains | Spoligoprofile |
| 1 | Beijing | 40 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ |
| 35 | Ural | 2 | ▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪□□□□▪▪▪▪▪▪▪ |
| 42 | LAM | 2 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ |
| 46 | Haarlem | 2 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□□□□□□□□ |
| 47 | Haarlem | 2 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□▪□□□□▪▪▪▪▪▪▪ |
| 50 | Haarlem | 6 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪□□□□▪▪▪▪▪▪▪ |
| 52 | T2 | 1 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪□▪▪▪ |
| 53 | T1 | 8 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ |
| 102 | T | 3 | ▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ |
| 252 | LAM | 8 | ▪▪▪▪▪▪▪▪▪▪□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ |
| 254 | LAM | 3 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ |
| 262 | Ural | 3 | ▪▪▪▪▪▪▪□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪□□□□▪▪▪▪▪▪▪ |
| 266 | LAM | 2 | ▪▪▪▪▪▪▪□▪▪▪▪▪□□□□□□□□□□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ |
| 267 | LAM | 1 | ▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ |
| 444 | LAM | 2 | ▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□□▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ |
| 1288 | Manu2 | 1 | ▪▪▪▪▪▪▪▪▪▪□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪□□▪▪▪▪▪▪▪▪▪ |
| 2021 | T | 1 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□▪▪▪ |
| 3108 | unknown | 2 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□▪▪▪▪□▪▪ |
| ‘new’ | unknown | 1 | ▪▪▪▪▪▪▪▪□□▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪ |
according to SITVITWEB [10].
Figure 1Geographic distribution of the main spoligotypes and genetic families identified in M tuberculosis strains in Pskov region and other areas in Russia, former Soviet Union and northern Europe.
Global distribution of the MIRU profiles identified in M. tuberculosis Beijing genotype strains from Pskov.
| Type, % in database (if >0.5%) | 12-MIRU-loci profile | Pskov, number (%) | Former Soviet Union, area and % | Mainland China, area and % | East Asia other than China, country and % |
| M2 (14.8) | 223325153533 | 13 (32.5) | Northwest 53, Samara 58, Kaliningrad 17, Ural 24, Irkutsk 50, South Ukraine 42, Kyrgyzstan 73 | Beijing 2.7, Shanghai 2.7, Wuhan 3.6, Henan 6.2, | Japan 0.5 |
| M11 (25.4) | 223325173533 | 11 (27.5) | Northwest 21, Samara 24, Ural 56, Irkutsk 26, Kaliningrad 65, South Ukraine 26, Kyrgyzstan 2.6 | Beijing 46, Shanghai 12, Wuhan 13, Henan 19 | Japan 24, Laos 28, Mongolia 66, Vietnam 21 |
| M8 | 22325173533 | 2 (5) | Northwest 2.1, Ural 2 | Beijing 2.7, Wuhan 17, Henan 3.1 | Japan 0.3 |
| M40 (0.5) | 223325153523 | 1 (2.5) | Kaliningrad 2.5, Irkutsk 3.5, Kyrgyzstan 2.6 | Shanghai 1.3 | |
| M9 | 22335173531 | 2 (5) | Northwest 2.1, Kaliningrad 2.5 | Beijing 2.7, Shanghai 1.3, Henan 3.1 | Mongolia 11, Vietnam 1.9 |
| M12 | 22135173533 | 1 (2.5) | Northwest 2.1, Samara 1.6, Ural 6, Kaliningrad 2.5 | Beijing 1.3, Shanghai 1.3, Henan 6.2 | Japan 13 |
| M39 | 22235153533 | 1 (2.5) | |||
| M41 | 22435173533 | 1 (2.5) | Kaliningrad 5 | Japan 0.3, Vietnam 1.9 | |
| M89 | 22335153534 | 3 (7.5) | Ural 2, Irkutsk 0.9 | ||
| M112 | 22335193533 | 1 (2.5) | Beijing 1.3 | ||
| M216 | 22325151534 | 1 (2.5) | |||
| M219 | 22334173533 | 1 (2.5) | Japan 0.3 | ||
| M224 | 22335154533 | 1 (2.5) | |||
| M231 | 22336153533 | 1 (2.5) |
according to the updated version (2400 strains) of the MIRU global database of Beijing genotype [14], [15] updated with more recent raw data on Henan, Mongolia, Japan-Osaka [44], Laos [45], Ukraine [32], Kaliningrad [30], Kyrgyzstan [21].
Figure 2Geographic distribution of the main MIRU types of the Beijing genotypes identified in the Pskov region and other areas of the former Soviet Union and Asia.
Figure 3Minimum spanning tree of the 12-MIRU-VNTR profiles of the Beijing strains from the Pskov region in the northwestern Russia.
12-loci digital profile is shown in the 1st line at the each node, alleles of 3 HV loci (VNTR-4120, VNTR-3820, QUB-3232) are shown in the 2nd line. Locus number and allele change are shown on branches. Circle size is roughly proportional to the number of strains.
Discriminatory capacity of different VNTR typing schemes applied to the Beijing genotype strains from the Pskov region in the northwestern Russia.
| Characteristic | 12-MIRU loci | +3 HV | +3232 | +3820 | +4120 | +3232 and 3820 | +3232 and 4120 | +3820 and 4120 |
| Cluster | 2–13 | 2–10 | 2–10 | 2–11 | 2–10 | 2–10 | 2–10 | 2–10 |
| Number of clusters | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 5 |
| Clustered | 31 | 26 | 27 | 27 | 29 | 26 | 27 | 26 |
| Singletons | 9 | 14 | 13 | 13 | 11 | 14 | 13 | 14 |
| HGI | 0.823 | 0.896 | 0.886 | 0.873 | 0.885 | 0.896 | 0.886 | 0.896 |
Three hypervariable (HV) loci, namely, QUB3232, VNTR3820, VNTR4120.
Cluster is defined as a group of strains with identical multi-locus digital signature.
Drug susceptibility and prevalence of drug resistance mutations in M. tuberculosis strains of Beijing, LAM and other genotypes isolated from TB patients in Pskov region of Russia.
| Phenotype | All strains, n = 90 | Beijing genotype, n = 40 | LAM genotype, n = 18 | Other genotypes, n = 32 | Beijing M2, n = 13 | Beijing M11, n = 11 |
| Fully susceptible | 34 | 5 | 5 | 24 | 0 | 0 |
| RIF-resistant | 43 | 26 | 10 | 7 | 12 | 9 |
| INH-resistant | 50 | 30 | 13 | 7 | 13 | 10 |
| STR-resistant | 55 | 34 | 13 | 8 | 13 | 11 |
| EMB-resistant | 33 | 17 | 10 | 6 | 10 | 4 |
| PZA-resistant | 6 | 3 | 2 | 1 | 2 | 1 |
| OFL-resistant | 6 | 4 | 2 | - | 1 | 1 |
| ETH-resistant | 12 | 3 | 8 | 1 | 1 | - |
| KAN-resistant | 16 | 5 | 7 | 4 | 3 | 1 |
| CAP-resistant | 11 | 2 | 6 | 3 | - | - |
| MDR | 42 | 25 | 10 | 7 | 12 | 9 |
| XDR | 5 | 3 | 2 | - | 1 | - |
|
| 24 | 19 | - | 5 | 10 | 6 |
|
| 2 | 1 | 1 | - | 1 | 1 |
|
| 8 | - | 8 | - | - | - |
|
| 1 | - | - | 1 | - | - |
|
| 1 | - | - | 1 | - | - |
|
| 2 | 1 | 1 | - | - | - |
|
| 52 | 19 | 8 | 25 | 2 | 4 |
|
| 44 | 26 | 12 | 6 | 12 | 8 |
|
| 10 | - | 10 | - | - | - |
|
| 10 | - | 10 | - | - | - |
RIF, rifampin; INH, isoniazid; STR, streptomycin; EMB, ethambutol; PZA, pyrazinamide; OFL, ofloxacin; ETH, ethionamide; KAN, kanamycin; CAP, capreomycin; MDR, multidrug-resistant; XDR, extremely drug resistant.
Drug susceptibility of M. tuberculosis strains of different genotypes from newly-diagnosed and previously-treated patients.
| Characteristic | Newly-diagnosed patients (n = 65), number, % | Drug-resistant strains of the respective genotype, number, % | Previously-treated patients (n = 25), number, % |
| Genotype | |||
| Beijing | 29, 44.6 | 23, 79.3 | 11, 44.0 |
| LAM | 9, 13.8 | 4, 44.4 | 9, 36.0 |
| Haarlem | 7, 10.8 | 1, 14.3 | 2, 8.0 |
| T | 12, 18.5 | 1, 8.3 | 1, 4.0 |
| Ural | 4, 6.2 | 2, 50.0 | 1, 4.0 |
| Phenotype | |||
| Drug-resistant | 31, 47.7 | 24, 96.0 | |
| Drug-susceptible | 34, 52.3 | 1, 4.0 |